#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	974	CRP	633	633	99.53	CRP.l6.c30.ctg.1	1321	39.8	0	.	p	.	0	K29T	NONSYN	85	87	AAG	393	395	ACG	46;47;47	A;C;G	46;47;47	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3582	Escherichia_coli_EF_Tu	1230	1209	99.75	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1478	119.5	1	SNP	p	R234F	1	.	.	700	702	TTC	969	971	TTC	153;154;153	T;T;C	152;153;153	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3582	Escherichia_coli_EF_Tu	1230	1209	99.75	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1478	119.5	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1269	1271	CGT	168;168;168	C;G;T	168;168;168	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3582	Escherichia_coli_EF_Tu	1230	1209	99.75	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1478	119.5	0	HET	.	.	.	T180C	.	180	180	T	449	449	T	105	T,C	57,42	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3582	Escherichia_coli_EF_Tu	1230	1209	99.75	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1478	119.5	0	HET	.	.	.	C261T	.	261	261	C	530	530	C	142	C,T	80,58	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3582	Escherichia_coli_EF_Tu	1230	1209	99.75	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1478	119.5	0	HET	.	.	.	C144T	.	144	144	C	413	413	C	98	C,T	68,30	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3582	Escherichia_coli_EF_Tu	1230	72	100.0	Escherichia_coli_EF_Tu.l15.c30.ctg.3	244	24.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1186	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l6.c4.ctg.1	1900	33.5	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1595	1597	AAA	19;18;18	A;A;A	19;18;18	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1982	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l6.c30.ctg.1	1963	54.2	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1294	1296	GAA	73;71;71	G;A;A	73;71;71	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	706	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	1068	35.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	222	G	221	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	202	C	202	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	193	C	192	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	213	T	212	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	296	C	295	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	185	C	184	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	161	A	161	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	157	A	157	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	157	A	156	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	139	T	139	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	141	C	141	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	139	C	138	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	141	A	139	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	142	G	140	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	141	C	140	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	155	T	155	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	212	G	211	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	237	G	232	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	243	T	242	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	234	T	234	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	222	G	221	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	173	C	173	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	167	A	167	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	160	C	160	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	161	C	161	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	81	A	81	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	81	A	81	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	80	G	80	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	85	C	85	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	142	T	142	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	157	G	157	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	151	T	150	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	836	150.0	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	313	C	312	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	109	93.58	Pasteurella_multocida_16S.l15.c17.ctg.5	163	60.7	0	.	n	.	0	T50C	SNP	50	50	T	103	103	C	65	C	65	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	109	93.58	Pasteurella_multocida_16S.l15.c17.ctg.5	163	60.7	0	.	n	.	0	G74A	SNP	74	74	G	127	127	A	13	A	13	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	109	93.58	Pasteurella_multocida_16S.l15.c17.ctg.5	163	60.7	0	.	n	.	0	G81.	DEL	81	81	G	133	133	A	12	A	12	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	109	93.58	Pasteurella_multocida_16S.l15.c17.ctg.5	163	60.7	0	.	n	.	0	A83C	SNP	83	83	A	135	135	C	12	C	12	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	109	93.58	Pasteurella_multocida_16S.l15.c17.ctg.5	163	60.7	0	.	n	.	0	T93G	SNP	93	93	T	144	144	G	13	G	12	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	5604	Pasteurella_multocida_16S	1551	109	93.58	Pasteurella_multocida_16S.l15.c17.ctg.5	163	60.7	0	.	n	.	0	T97C	SNP	97	97	T	148	148	C	12	C	12	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1478	PmrB_1	1092	1092	99.08	PmrB_1.l6.c4.ctg.1	1644	48.0	0	.	p	.	0	H2R	NONSYN	4	6	CAT	341	343	CGT	49;55;53	C;G;T	49;55;53	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1478	PmrB_1	1092	1092	99.08	PmrB_1.l6.c4.ctg.1	1644	48.0	0	.	p	.	0	V30I	NONSYN	88	90	GTC	425	427	ATC	61;60;60	A;T;C	60;60;60	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1478	PmrB_1	1092	1092	99.08	PmrB_1.l6.c4.ctg.1	1644	48.0	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1184	1186	GGC	66;66;65	G;G;C	66;66;65	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2292	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2211	55.7	0	.	p	.	0	R8S	NONSYN	22	24	AGA	305	307	AGC	41;44;44	A;G;C	41;44;44	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2292	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2211	55.7	0	.	p	.	0	I142L	NONSYN	424	426	ATA	707	709	CTA	52;52;52	C;T;A	52;52;52	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2292	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2211	55.7	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1226	1228	CAA	77;76;75	C;A;A	77;75;75	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2292	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2211	55.7	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1325	1327	GGT	75;74;71	G;G;T	75;74;71	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2292	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2211	55.7	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1895	1897	GTT	38;38;38	G;T;T	38;38;38	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	868	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1637	28.5	0	.	p	.	0	A125E	NONSYN	373	375	GCA	642	644	GAA	36;33;33	G;A;A	36;33;33	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	868	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1637	28.5	0	.	p	.	0	M185T	NONSYN	553	555	ATG	822	824	ACC	13;12;12	A;C;C	13;12;12	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	868	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1637	28.5	0	.	p	.	0	S225T	NONSYN	673	675	TCC	942	944	ACT	13;14;14	A;C;T	13;14;14	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	868	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1637	28.5	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1332	1334	ATC	22;22;22	A;T;C	21;22;22	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	944	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1463	34.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3460	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3656	50.8	0	.	p	.	0	T85I	NONSYN	253	255	ACC	588	590	ATC	63;62;64	A;T;C	63;61;64	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3460	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3656	50.8	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2301	2303	AAG	33;32;33	A;A;G	33;32;33	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1372	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1671	43.9	0	.	p	.	0	A22V	NONSYN	64	66	GCC	315	317	GTC	24;24;25	G;T;C	24;24;25	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1372	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1671	43.9	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1056	1058	TGC	62;55;55	T;G;C	62;55;55	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3266	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3189	54.8	0	.	p	.	0	S46trunc	TRUNC	136	136	T	453	453	T	35	T	34	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3266	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3189	54.8	0	.	p	.	0	G148D	NONSYN	442	444	GGC	759	761	GAC	59;58;59	G;A;C	59;56;59	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3266	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3189	54.8	0	.	p	.	0	F240L	NONSYN	718	720	TTT	1035	1037	TTA	40;41;39	T;T;A	40;41;39	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3266	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3189	54.8	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1218	1220	AAT	66;65;67	A;A;T	64;63;66	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3266	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3189	54.8	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	2005	2005	T	75	T	75	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	914	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1218	40.3	1	SNP	p	R45C	0	.	.	133	135	CGC	443	445	CGC	66;66;67	C;G;C	66;66;67	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	844	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1098	41.2	0	.	p	.	0	L34F	NONSYN	100	102	CTC	291	293	TTC	36;36;36	T;T;C,A	36;36;35,1	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	844	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1098	41.2	0	.	p	.	0	E122G	NONSYN	364	366	GAG	555	557	GGG	64;64;65	G;G;G	64;64;65	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	1112	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1260	47.1	0	.	p	.	0	V136L	NONSYN	406	408	GTT	599	601	CTT	66;66;66	C;T;T	66;66;66	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3186	alaS	2631	2631	98.86	alaS.l6.c30.ctg.1	3198	53.6	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2097	2099	GCA	69;70;70	G;C;A	69;69;70	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3186	alaS	2631	2631	98.86	alaS.l6.c30.ctg.1	3198	53.6	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2358	2360	ACC	47;47;49	A;C;C	45;47;48	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3186	alaS	2631	2631	98.86	alaS.l6.c30.ctg.1	3198	53.6	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2667	2669	GCC	66;66;67	G;C;C	66;66;67	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1538	arnA_1	1983	1983	98.24	arnA_1.l15.c4.ctg.1	2331	35.4	0	.	p	.	0	G37A	NONSYN	109	111	GGT	291	293	GCT	10;12;12	G;C;T	10;12;12	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1538	arnA_1	1983	1983	98.24	arnA_1.l15.c4.ctg.1	2331	35.4	0	.	p	.	0	D77E	NONSYN	229	231	GAT	411	413	GAG	11;11;11	G;A;G	10;11;10	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1538	arnA_1	1983	1983	98.24	arnA_1.l15.c4.ctg.1	2331	35.4	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	447	449	TGC	13;13;14	T;G;C	13;13;14	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1538	arnA_1	1983	1983	98.24	arnA_1.l15.c4.ctg.1	2331	35.4	0	.	p	.	0	I150V	NONSYN	448	450	ATT	630	632	GTT	27;28;28	G;T,A;T	27;26,1;28	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1538	arnA_1	1983	1983	98.24	arnA_1.l15.c4.ctg.1	2331	35.4	0	.	p	.	0	R200H	NONSYN	598	600	CGC	780	782	CAC	40;40;39	C;A;C	40;40;39	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1538	arnA_1	1983	1983	98.24	arnA_1.l15.c4.ctg.1	2331	35.4	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1065	1067	ATG	49;49;49	A;T;G	49;49;49	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1538	arnA_1	1983	1983	98.24	arnA_1.l15.c4.ctg.1	2331	35.4	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2061	2063	CGC	37;36;37	C;G;C	37;36;37	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	976	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1409	37.1	0	.	p	.	0	S221T	NONSYN	661	663	AGC	970	972	ACC	28;27;27	A;C;C	28;27;27	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	976	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1409	37.1	0	.	p	.	0	P225S	NONSYN	673	675	CCG	982	984	TCG	26;26;25	T;C;G	25;26;25	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	668	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1195	29.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1228	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1959	33.7	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1380	1382	AAA	18;19;18	A;A;A	17;19;18	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1228	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1959	33.7	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1392	1394	GAG	18;18;18	G;A;G	18;18;18	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1228	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1959	33.7	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1398	1400	CAC	18;19;20	C;A;C	18;19;20	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1228	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1959	33.7	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1452	1454	GAG	33;32;31	G;A;G	33;32;30	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1722	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1950	47.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	1144	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1245	49.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	964	cysB	975	975	99.28	cysB.l15.c30.ctg.1	1490	34.6	0	.	p	.	0	A146T	NONSYN	436	438	GCT	692	694	ACT	46;44;44	A,G;C;T	45,1;44;44	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	768	dfrA1_1	474	474	100.0	dfrA1_1.l15.c30.ctg.1	1026	40.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli;dfrA1
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1224	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1679	39.2	0	.	p	.	0	I219V	NONSYN	655	657	ATC	900	902	GTC	52;51;50	G;T;C	52;51;49	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1972	emrB	1539	1539	99.74	emrB.l15.c4.ctg.1	2161	49.0	0	.	p	.	0	E197K	NONSYN	589	591	GAA	887	889	AAA	64;64;65	A;A;A	63;64;64	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1446	emrD	1191	1191	98.4	emrD.l15.c30.ctg.1	1803	43.2	0	.	p	.	0	G209S	NONSYN	625	627	GGC	899	901	AGC	52;53;53	A;G;C	51;52;53	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	58	emrE_1	333	95	96.84	emrE_1.l15.c17.ctg.1	95	15.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1702	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1653	55.5	0	.	p	.	0	K176R	NONSYN	526	528	AAG	792	794	AGG	60;58;58	A;G;G	60;58;58	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1702	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1653	55.5	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1182	1184	GAC	55;55;54	G;A;C	55;55;54	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	756	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1116	36.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	2584	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	2206	63.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	1062	evgA	615	615	99.19	evgA.l15.c4.ctg.1	1289	44.3	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	545	547	CTG	77;75;72	C;T;G	76;75;72	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	T38I	NONSYN	112	114	ACA	368	370	ATA	32;32;32	A;T;A	32;32;32	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	L42V	NONSYN	124	126	CTA	380	382	GTA	28;28;28	G;T;A	28;28;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	A93T	NONSYN	277	279	GCG	533	535	ACG	54;54;50	A;C;G	54;54;50	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	A114E	NONSYN	340	342	GCA	596	598	GAA	47;46;48	G;A;A	47;46;48	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	T127A	NONSYN	379	381	ACT	635	637	GCT	45;45;46	G;C;T	45;45;46	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	N133D	NONSYN	397	399	AAT	653	655	GAT	40;41;41	G;A;T	40;41;41	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	P162S	NONSYN	484	486	CCA	740	742	TCA	40;40;38	T;C;A	39;39;37	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	869	871	CAG	45;45;46	C;A;G	45;45;46	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1007	1009	GTT	43;44;43	G;T;T	43;44;43	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1163	1165	GAT	27;28;28	G;A;T	27;27;28	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1331	1333	AAT	40;40;40	A;A;T	40;40;40	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1352	1354	TTA	23;23;23	T;T;A	23;23;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1553	1555	AAA	34;33;33	A;A;A	34;33;33	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2288	2290	CAT	55;57;56	C;A;T	55;56;56	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2342	2344	CAT	41;40;41	C;A;T	41;40;41	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2360	2362	AGA	47;49;48	A;G;A	47;49;48	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2375	2377	AAT	48;49;49	A;A;T	47;49;49	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2522	2524	TCC	62;59;58	T;C;C	61;59;58	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2687	2689	ATT	52;51;51	A;T;T	52;51;51	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2708	2710	GAT	66;68;71	G;A,G;T	65;67,1;70	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2822	2824	GTT	50;51;50	G;T;T	50;51;50	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4818	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4099	63.1	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3107	3109	CAC	72;73;70	C;A;C	72;72;70	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1130	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1517	39.9	1	SNP	p	P64A	0	.	.	190	192	CCA	487	489	CCA	79;80;79	C;C;A	78;79;76	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1130	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1517	39.9	1	SNP	p	P64L	0	.	.	190	192	CCA	487	489	CCA	79;80;79	C;C;A	78;79;76	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1130	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1517	39.9	1	SNP	p	P64R	0	.	.	190	192	CCA	487	489	CCA	79;80;79	C;C;A	78;79;76	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1130	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1517	39.9	1	SNP	p	P64S	0	.	.	190	192	CCA	487	489	CCA	79;80;79	C;C;A	78;79;76	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1130	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1517	39.9	1	SNP	p	P64H	0	.	.	190	192	CCA	487	489	CCA	79;80;79	C;C;A	78;79;76	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	760	gadE	528	528	100.0	gadE.l6.c4.ctg.1	1200	33.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	214	gadW	729	584	94.18	gadW.l15.c30.ctg.1	775	14.5	0	.	p	.	0	E54D	NONSYN	160	162	GAA	15	17	GAT	7;8;8	G;A;T	7;8;8	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	214	gadW	729	584	94.18	gadW.l15.c30.ctg.1	775	14.5	0	.	p	.	0	I88M	NONSYN	262	264	ATA	117	119	ATG	11;11;10	A;T;G	11;11;10	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	214	gadW	729	584	94.18	gadW.l15.c30.ctg.1	775	14.5	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	120	122	CCG	10;10;10	C;C;G	10;10;10	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	214	gadW	729	584	94.18	gadW.l15.c30.ctg.1	775	14.5	0	.	p	.	0	D100E	NONSYN	298	300	GAC	153	155	GAA	10;11;11	G;A;A	10;11;11	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	214	gadW	729	584	94.18	gadW.l15.c30.ctg.1	775	14.5	0	.	p	.	0	P101S	NONSYN	301	303	CCC	156	158	TCC	10;9;9	T;C;C	10;9;9	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	214	gadW	729	584	94.18	gadW.l15.c30.ctg.1	775	14.5	0	.	p	.	0	R102G	NONSYN	304	306	CGG	159	161	GGG	9;9;9	G;G;G	9;9;9	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	214	gadW	729	584	94.18	gadW.l15.c30.ctg.1	775	14.5	0	.	p	.	0	K110N	NONSYN	328	330	AAA	183	185	AAT	9;9;9	A;A;T	9;9;9	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	214	gadW	729	584	94.18	gadW.l15.c30.ctg.1	775	14.5	0	.	p	.	0	S234A	NONSYN	700	702	TCG	555	557	GCG	15;15;15	G;C;G	15;15;15	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	826	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1281	34.6	0	.	p	.	0	F53L	NONSYN	157	159	TTC	427	429	TTA	31;30;30	T;T;A	31;30;30	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	826	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1281	34.6	0	.	p	.	0	V79I	NONSYN	235	237	GTT	505	507	ATT	45;42;43	A;T;T	45;42;43	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	826	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1281	34.6	0	.	p	.	0	R246G	NONSYN	736	738	AGA	1006	1008	GGA	23;25;26	G;G;A	23;25;25	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	826	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1281	34.6	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1012	1014	CCG	22;21;21	C;C;G	22;21;21	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3026	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3310	49.1	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2428	2430	GAA	55;54;54	G;A;A	53;52;52	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3026	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3310	49.1	1	SNP	p	S83W	0	.	.	247	249	TCG	643	645	TCG	62;62;61	T;C,T;G	61;60,1;61	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3026	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3310	49.1	1	SNP	p	S83L	0	.	.	247	249	TCG	643	645	TCG	62;62;61	T;C,T;G	61;60,1;61	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3026	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3310	49.1	1	SNP	p	S83I	0	.	.	247	249	TCG	643	645	TCG	62;62;61	T;C,T;G	61;60,1;61	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3026	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3310	49.1	1	SNP	p	D87N	0	.	.	259	261	GAC	655	657	GAC	57;58;56	G;A;C	54;57;53	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3026	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3310	49.1	1	SNP	p	D87Y	0	.	.	259	261	GAC	655	657	GAC	57;58;56	G;A;C	54;57;53	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3026	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3310	49.1	1	SNP	p	D87H	0	.	.	259	261	GAC	655	657	GAC	57;58;56	G;A;C	54;57;53	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3026	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3310	49.1	1	SNP	p	D87G	0	.	.	259	261	GAC	655	657	GAC	57;58;56	G;A;C	54;57;53	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3026	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3310	49.1	1	SNP	p	D87V	0	.	.	259	261	GAC	655	657	GAC	57;58;56	G;A;C	54;57;53	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3042	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2960	55.1	1	SNP	p	R136L	0	.	.	406	408	CGC	715	717	CGC	70;70;68	C;G;C	69;69;67	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3042	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2960	55.1	1	SNP	p	R136I	0	.	.	406	408	CGC	715	717	CGC	70;70;68	C;G;C	69;69;67	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3042	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2960	55.1	1	SNP	p	R136H	0	.	.	406	408	CGC	715	717	CGC	70;70;68	C;G;C	69;69;67	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3042	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2960	55.1	1	SNP	p	R136S	0	.	.	406	408	CGC	715	717	CGC	70;70;68	C;G;C	69;69;67	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3042	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2960	55.1	1	SNP	p	R136C	0	.	.	406	408	CGC	715	717	CGC	70;70;68	C;G;C	69;69;67	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3042	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2960	55.1	1	SNP	p	R136G	0	.	.	406	408	CGC	715	717	CGC	70;70;68	C;G;C	69;69;67	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3042	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2960	55.1	1	SNP	p	R136E	0	.	.	406	408	CGC	715	717	CGC	70;70;68	C;G;C	69;69;67	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	684	kdpE	678	678	98.23	kdpE.l6.c30.ctg.1	1137	32.0	0	.	p	.	0	A72P	NONSYN	214	216	GCG	447	449	CCG	44;43;42	C;C;G	44;43;42	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	684	kdpE	678	678	98.23	kdpE.l6.c30.ctg.1	1137	32.0	0	.	p	.	0	T123A	NONSYN	367	369	ACC	600	602	GCC	35;35;36	G;C;C	35;35;36	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1290	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1492	46.5	0	.	p	.	0	P9S	NONSYN	25	27	CCA	255	257	TCA	20;22;23	T;C;A	20;21;23	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	410	marA	384	384	99.74	marA.l15.c4.ctg.1	869	25.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	312	marR	435	420	97.62	marR.l15.c4.ctg.1	733	21.5	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	620	622	AGC	15;15;14	A;G;C	15;15;14	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	312	marR	435	420	97.62	marR.l15.c4.ctg.1	733	21.5	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	722	724	CAT	5;4;3	C;A;T	4;4;3	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	312	marR	435	420	97.62	marR.l15.c4.ctg.1	733	21.5	1	SNP	p	V45E	0	.	.	133	135	GTG	446	448	GTG	36;32;32	G;T;G	35;31;32	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	312	marR	435	420	97.62	marR.l15.c4.ctg.1	733	21.5	1	SNP	p	I49S	0	.	.	145	147	ATC	458	460	ATC	34;33;32	A;T;C	34;33;32	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	312	marR	435	420	97.62	marR.l15.c4.ctg.1	733	21.5	1	SNP	p	A70T	0	.	.	208	210	GCA	521	523	GCA	39;38;39	G;C;A	39;38;39	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	312	marR	435	420	97.62	marR.l15.c4.ctg.1	733	21.5	1	SNP	p	R73S	0	.	.	217	219	CGT	530	532	CGT	36;35;35	C;G;T	36;35;35	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	312	marR	435	420	97.62	marR.l15.c4.ctg.1	733	21.5	1	SNP	p	R73C	0	.	.	217	219	CGT	530	532	CGT	36;35;35	C;G;T	36;35;35	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	312	marR	435	420	97.62	marR.l15.c4.ctg.1	733	21.5	1	SNP	p	R77L	0	.	.	229	231	CGC	542	544	CGC	31;31;31	C;G;C	31;31;31	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	312	marR	435	420	97.62	marR.l15.c4.ctg.1	733	21.5	1	SNP	p	R77C	0	.	.	229	231	CGC	542	544	CGC	31;31;31	C;G;C	31;31;31	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	312	marR	435	420	97.62	marR.l15.c4.ctg.1	733	21.5	1	SNP	p	L78M	0	.	.	232	234	CTG	545	547	CTG	31;32;31	C;T;G	31;32;30	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	312	marR	435	420	97.62	marR.l15.c4.ctg.1	733	21.5	1	SNP	p	R94S	0	.	.	280	282	CGC	593	595	CGC	18;18;18	C;G;C	18;18;18	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	312	marR	435	420	97.62	marR.l15.c4.ctg.1	733	21.5	1	SNP	p	R94H	0	.	.	280	282	CGC	593	595	CGC	18;18;18	C;G;C	18;18;18	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	312	marR	435	420	97.62	marR.l15.c4.ctg.1	733	21.5	1	SNP	p	V96E	0	.	.	286	288	GTA	599	601	GTA	19;18;17	G;T;A	19;18;17	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	984	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1784	29.5	0	.	p	.	0	S7F	NONSYN	19	21	TCC	225	227	TTC	7;7;7	T;T;C	7;7;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	984	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1784	29.5	0	.	p	.	0	R36I	NONSYN	106	108	AGG	312	314	ATC	24;25;25	A;T;C	24;24;25	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	984	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1784	29.5	0	.	p	.	0	E42A	NONSYN	124	126	GAA	330	332	GCC	11;11;12	G;C;C	11;11;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	984	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1784	29.5	0	.	p	.	0	N43V	NONSYN	127	129	AAT	333	335	GTG	11;12;12	G;T;G	11;11;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	984	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1784	29.5	0	.	p	.	0	E52D	NONSYN	154	156	GAG	360	362	GAT	19;18;19	G;A;T	18;17;18	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	984	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1784	29.5	0	.	p	.	0	N59T	NONSYN	175	177	AAC	381	383	ACC	18;17;17	A;C;C	18;17;17	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	984	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1784	29.5	0	.	p	.	0	I68L	NONSYN	202	204	ATA	408	410	TTA	19;19;19	T;T;A	19;19;19	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	984	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1784	29.5	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	549	551	CAG	56;55;53	C;A;G	56;55;52	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	984	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1784	29.5	0	.	p	.	0	D128A	NONSYN	382	384	GAC	588	590	GCC	36;36;37	G;C;C	36;36;37	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	984	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1784	29.5	0	.	p	.	0	S163A	NONSYN	487	489	TCG	693	695	GCG	47;46;48	G;C;G	47;46;48	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	984	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1784	29.5	0	.	p	.	0	L231V	NONSYN	691	693	CTT	897	899	GTT	32;32;32	G;T;T	28;29;29	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	984	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1784	29.5	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1059	1059	C	37	C	37	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	936	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1762	28.5	0	.	p	.	0	V12trunc	TRUNC	34	34	G	250	250	G	28	G	27	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	936	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1762	28.5	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	307	309	CAG	20;19;19	C;A;G	20;19;19	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	936	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1762	28.5	0	.	p	.	0	T83I	NONSYN	247	249	ACC	457	459	ATC	33;32;30	A;T;C	33;32;30	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	936	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1762	28.5	0	.	p	.	0	I99M	NONSYN	295	297	ATA	505	507	ATG	24;23;24	A;T;G	24;23;24	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	936	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1762	28.5	0	.	p	.	0	A130T	NONSYN	388	390	GCC	598	600	ACC	29;28;28	A;C;C	29;28;28	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	936	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1762	28.5	0	.	p	.	0	P257T	NONSYN	769	771	CCG	979	981	ACG	35;36;36	A;C;G	35;35;36	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3026	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3467	46.8	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1963	1965	ACC	40;40;40	A;C;C	40;40;40	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3026	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3467	46.8	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2356	2358	CAA	30;30;32	C;A;A	30;30;32	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3026	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3467	46.8	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2524	2526	ATT	52;52;51	A;T;T	52;52;51	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3026	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3467	46.8	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2608	2610	GTT	34;34;34	G;T;T	34;34;34	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3026	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3467	46.8	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2716	2718	GAG	31;31;32	G;A;G	31;31;32	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3026	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3467	46.8	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2944	2946	ATG	42;43;44	A;T;G	42;43;44	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3026	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3467	46.8	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3079	3081	GAT	57;56;56	G,T;A;T	56,1;56;56	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2690	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3559	40.5	0	.	p	.	0	I46M	NONSYN	136	138	ATC	359	361	ATG	19;19;19	A;T;G	17;17;17	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2690	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3559	40.5	0	.	p	.	0	V208I	NONSYN	622	624	GTC	845	847	ATC	47;46;48	A;T;C	47;46;48	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2690	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3559	40.5	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3161	3163	CAC	14;14;14	C;A,C;C	14;12,1;14	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2690	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3559	40.5	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3164	3166	CTC	14;13;11	C;T;C	13;12;9	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1498	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1946	41.3	0	.	p	.	0	D3E	NONSYN	7	9	GAT	265	267	GAA	32;32;31	G;A;A	32;32;31	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1498	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1946	41.3	0	.	p	.	0	T226A	NONSYN	676	678	ACG	934	936	GCG	55;55;55	G;C;G	54;54;55	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1498	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1946	41.3	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1276	1278	ATC	45;45;44	A;T;C	44;44;44	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1498	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1946	41.3	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1579	1581	TTT	53;55;55	T;T;T	53;55;55	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1654	mdtE	1158	1158	99.31	mdtE.l6.c17.ctg.1	1806	49.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3878	mdtF	3114	3114	98.52	mdtF.l6.c4.ctg.1	3644	57.1	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1132	1134	ACC	54;55;54	A;C;C	53;51;53	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3878	mdtF	3114	3114	98.52	mdtF.l6.c4.ctg.1	3644	57.1	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2374	2376	GAC	75;75;75	G;A;C	74;74;75	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1386	mdtG	1227	1047	99.33	mdtG.l15.c17.ctg.1	1640	36.7	0	.	p	.	0	V200I	NONSYN	598	600	GTC	717	719	ATC	36;36;38	A;T;C	36;36;38	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1386	mdtG	1227	182	99.45	mdtG.l15.c17.ctg.2	632	21.7	0	.	p	.	0	E5G	NONSYN	13	15	GAA	191	193	GGA	20;21;22	G;G;A	20;21;22	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1056	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1671	34.0	0	.	p	.	0	G134C	NONSYN	400	402	GGT	657	659	TGT	44;44;44	T;G;T	43;44;43	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1056	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1671	34.0	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1227	1229	TTG	49;47;47	T;T;G	49;47;47	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1056	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1671	34.0	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1437	1439	ACG	15;16;15	A;C;G	15;16;15	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1548	mdtL	1176	1176	98.38	mdtL.l15.c30.ctg.1	1810	45.9	0	.	p	.	0	A185S	NONSYN	553	555	GCC	886	888	TCC	52;52;54	T;C;C	48;52;54	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	1256	mdtN	1032	1032	98.02	mdtN.l15.c30.ctg.1	1685	40.1	0	.	p	.	0	V119I	NONSYN	355	357	GTT	621	623	ATT	47;48;49	A;T;T	46;48;49	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2238	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2579	46.6	0	.	p	.	0	V11M	NONSYN	31	33	GTG	266	268	ATG	25;27;28	A;T;G	25;27;28	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2238	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2579	46.6	0	.	p	.	0	T33I	NONSYN	97	99	ACC	332	334	ATC	26;25;25	A;T;C	26;23;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2238	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2579	46.6	0	.	p	.	0	C116R	NONSYN	346	348	TGC	581	583	CGC	50;50;50	C;G;C	49;48;50	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2238	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2579	46.6	0	.	p	.	0	N238S	NONSYN	712	714	AAC	947	949	AGC	60;60;61	A;G;C	60;60;61	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2238	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2579	46.6	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1148	1150	GTG	52;55;55	G;T;G	52;54;53	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2238	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2579	46.6	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1211	1213	AAC	33;33;32	A;A;C	31;30;31	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2238	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2579	46.6	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1256	1258	GTC	55;56;55	G;T;C	55;54;54	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2238	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2579	46.6	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1286	1288	ATA	62;61;59	A;T;A	62;60;59	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2238	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2579	46.6	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1394	1396	TCT	34;34;35	T;C;T	34;34;35	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2238	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2579	46.6	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1781	1783	GCG	48;46;46	G;C;G	48;45;46	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2238	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2579	46.6	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1994	1996	ATC	28;27;27	A;T;C	28;26;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1582	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1920	44.3	0	.	p	.	0	S129A	NONSYN	385	387	TCA	620	622	GCG	51;53;54	G;C;G	50;51;54	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1582	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1920	44.3	0	.	p	.	0	A187T	NONSYN	559	561	GCC	794	796	ACC	55;56;55	A;C;C	54;56;54	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1582	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1920	44.3	0	.	p	.	0	H211R	NONSYN	631	633	CAC	866	868	CGC	70;70;72	C;G;C	69;70;71	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1582	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1920	44.3	0	.	p	.	0	V250A	NONSYN	748	750	GTT	983	985	GCT	53;53;52	G;C;T	53;52;52	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1582	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1920	44.3	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1067	1069	AAA	29;27;25	A;A;A	29;27;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1582	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1920	44.3	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1085	1087	CGA	32;31;33	C;G;A	32;31;33	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1582	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1920	44.3	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1250	1252	GCC	48;48;48	G;C;C	47;47;47	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1582	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1920	44.3	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1262	1264	GAT	51;50;48	G;A;T	50;50;48	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1582	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1920	44.3	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1679	1681	GCT	18;17;16	G;C;T	18;17;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3484	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3911	47.8	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1544	1546	AAG	37;37;37	A;A;G	37;37;37	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3484	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3911	47.8	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2621	2623	CTG	43;44;45	C;T;G	43;44;45	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	218	mgrB	144	144	100.0	mgrB.l6.c30.ctg.1	656	17.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2102	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2263	50.0	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1074	1076	AAC	55;55;56	A;A;C	55;54;56	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2102	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2263	50.0	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1620	1622	ATA	57;59;60	A;T,G;A	57;58,1;60	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1650	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1754	50.5	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1349	1351	GAT	79;80;79	G;A;T	79;79;79	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1650	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1754	50.5	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1352	1354	CTG	80;80;79	C;T;G	80;79;79	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	968	nfsA	723	379	98.94	nfsA.l15.c4.ctg.1	800	34.5	0	.	p	.	0	R27C	NONSYN	79	81	CGT	267	269	TGT	40;39;39	T;G;T	40;39;38	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	968	nfsA	723	379	98.94	nfsA.l15.c4.ctg.1	800	34.5	0	.	p	.	0	I117T	NONSYN	349	351	ATC	537	539	ACC	44;44;44	A;C;C	42;44;44	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	968	nfsA	723	379	98.94	nfsA.l15.c4.ctg.1	800	34.5	1	SNP	p	R15C	0	.	.	43	45	CGC	231	233	CGC	77;77;75	C;G;C	77;76;75	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	968	nfsA	723	379	98.94	nfsA.l15.c4.ctg.1	800	34.5	1	SNP	p	S33R	0	.	.	97	99	AGC	285	287	AGC	38;35;35	A;G;C	38;35;35	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	968	nfsA	723	353	99.15	nfsA.l15.c4.ctg.2	827	28.6	0	.	p	.	0	G187D	NONSYN	559	561	GGC	417	419	GAC	51;52;51	G;A;C	51;52;51	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	968	nfsA	723	353	99.15	nfsA.l15.c4.ctg.2	827	28.6	1	SNP	p	G131D	0	.	.	391	393	GGC	249	251	GGC	34;33;32	G;G;C,A,G	34;32;29,1,1	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	968	nfsA	723	353	99.15	nfsA.l15.c4.ctg.2	827	28.6	1	SNP	p	R203C	0	.	.	607	609	CGT	465	467	CGT	60;59;60	C;G;T	60;58;60	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	968	nfsA	723	353	99.15	nfsA.l15.c4.ctg.2	827	28.6	1	SNP	p	R203L	0	.	.	607	609	CGT	465	467	CGT	60;59;60	C;G;T	60;58;60	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1458	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1722	45.5	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1233	1235	GAG	64;65;66	G;A;G	64;65;65	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1458	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1722	45.5	1	SNP	p	G141E	0	.	.	421	423	GGT	720	722	GGT	66;67;67	G;G;T	66;67;67	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1458	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1722	45.5	1	SNP	p	G141D	0	.	.	421	423	GGT	720	722	GGT	66;67;67	G;G;T	66;67;67	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1458	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1722	45.5	1	SNP	p	R154A	0	.	.	460	462	CGT	759	761	CGT	63;65;65	C;G;T	62;65;64	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1458	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1722	45.5	1	SNP	p	R154D	0	.	.	460	462	CGT	759	761	CGT	63;65;65	C;G;T	62;65;64	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3010	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2821	57.3	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1897	1899	GTG	74;73;75	G;T;G	74;72;75	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3010	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2821	57.3	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1924	1926	TCG	66;64;65	T;C;G	64;62;65	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3010	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2821	57.3	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2539	2541	AAC	46;45;45	A;A;C	46;45;45	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3010	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2821	57.3	1	SNP	p	A85T	0	.	.	253	255	GCG	553	555	GCG	61;61;60	G;C;G	59;60;60	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3010	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2821	57.3	1	SNP	p	D111H	0	.	.	331	333	GAT	631	633	GAT	63;64;65	G;A;T	63;64;65	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3010	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2821	57.3	1	SNP	p	S129P	0	.	.	385	387	TCC	685	687	TCC	60;58;58	T;C;C	58;57;57	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1892	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2507	40.4	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1731	1733	AAC	46;46;47	A;A;C	46;46;47	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1892	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2507	40.4	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1740	1742	GAT	57;56;54	G;A;T	56;56;54	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1894	patA	1380	1380	99.78	patA.l15.c30.ctg.1	2049	49.6	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	953	955	CAG	81;82;84	C;A;G	81;81;83	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1894	patA	1380	1380	99.78	patA.l15.c30.ctg.1	2049	49.6	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1427	1429	GAT	79;81;82	G,A;A;T	78,1;80;82	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5862	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4509	69.9	1	SNP	p	V146F	0	.	.	436	438	GTT	654	656	GTT	87;85;83	G,A;T;T	86,1;85;83	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5862	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4509	69.9	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1755	1757	CAG	82;80;86	C;A;G	82;80;86	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5862	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4509	69.9	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1755	1757	CAG	82;80;86	C;A;G	82;80;86	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5862	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4509	69.9	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1794	1796	CAC	69;69;70	C;A;C	69;68;70	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5862	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4509	69.9	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1803	1805	CGT	70;73;69	C;G;T	69;71;69	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5862	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4509	69.9	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1803	1805	CGT	70;73;69	C;G;T	69;71;69	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5862	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4509	69.9	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1809	1811	TCC	67;68;62	T;C;C	66;67;61	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5862	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4509	69.9	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1815	1817	CTC	63;63;64	C;T;C	63;63;64	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5862	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4509	69.9	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1905	1907	ACC	77;77;79	A;C;C	77;77;79	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5862	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4509	69.9	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1908	1910	CCT	78;78;78	C;C;T	78;78;78	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5862	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4509	69.9	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2277	2279	CGT	83;86;85	C;G;T	83;86;85	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1231	416.3	0	.	n	.	0	A226G	SNP	226	226	A	456	456	G	503	G	502	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1231	416.3	1	SNP	n	A794G	0	.	.	794	794	A	1024	1024	A	476	A,G	470,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1231	416.3	1	SNP	n	A794T	0	.	.	794	794	A	1024	1024	A	476	A,G	470,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1231	416.3	1	SNP	n	G926A	0	.	.	926	926	G	1156	1156	G	444	G	443	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1231	416.3	1	SNP	n	G926T	0	.	.	926	926	G	1156	1156	G	444	G	443	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1231	416.3	1	SNP	n	G926C	0	.	.	926	926	G	1156	1156	G	444	G	443	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1231	416.3	0	HET	.	.	.	A253T	.	253	253	A	483	483	A	463	A,T	362,97	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1231	416.3	0	HET	.	.	.	T90C	.	90	90	T	320	320	T	448	T,C	326,115	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1231	416.3	0	HET	.	.	.	C194T	.	194	194	C	424	424	C	513	C,T	406,104	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1231	416.3	0	HET	.	.	.	G474A	.	474	474	G	704	704	G	499	G,A	382,112	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1231	416.3	0	HET	.	.	.	A79G	.	79	79	A	309	309	A	461	A,G	340,119	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1231	416.3	0	HET	.	.	.	C719T	.	719	719	C	949	949	C	458	C,T	329,127	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1231	416.3	0	HET	.	.	.	T273A,G	.	273	273	T	503	503	T	480	T,A,G	371,102,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1231	416.3	0	HET	.	.	.	C183T	.	183	183	C	413	413	C	497	C,T	328,166	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1231	416.3	0	HET	.	.	.	A250T	.	250	250	A	480	480	A	473	A,T	374,98	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.3	518	477.2	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	336	A	331	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.3	518	477.2	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	336	A	331	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.3	518	477.2	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	336	A	331	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	139	95.0	rrsB+.l15.c30.ctg.4	139	121.2	0	.	n	.	0	G1002A	SNP	1002	1002	G	53	53	A	189	A	188	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	139	95.0	rrsB+.l15.c30.ctg.4	139	121.2	0	.	n	.	0	G1006C	SNP	1006	1006	G	57	57	C	196	C	196	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	139	95.0	rrsB+.l15.c30.ctg.4	139	121.2	0	.	n	.	0	T1010C	SNP	1010	1010	T	61	61	C	207	C	207	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	139	95.0	rrsB+.l15.c30.ctg.4	139	121.2	0	.	n	.	0	A1019.	DEL	1019	1019	A	69	69	G	215	G	215	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	139	95.0	rrsB+.l15.c30.ctg.4	139	121.2	0	.	n	.	0	.1023G	INS	1023	1023	T	74	74	G	212	G	212	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	139	95.0	rrsB+.l15.c30.ctg.4	139	121.2	0	.	n	.	0	C1038T	SNP	1038	1038	C	89	89	T	202	T	202	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	15788	rrsB+	1542	143	100.0	rrsB+.l15.c30.ctg.5	143	93.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	932	sat_1	525	525	100.0	sat_1.l15.c30.ctg.1	1019	48.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli;sat-1
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	748	soxR	465	465	100.0	soxR.l15.c30.ctg.1	934	42.8	1	SNP	p	R20H	0	.	.	58	60	CGC	271	273	CGC	59;60;59	C;G;C	59;60;59	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	748	soxR	465	465	100.0	soxR.l15.c30.ctg.1	934	42.8	1	SNP	p	G121D	0	.	.	361	363	GGT	574	576	GGT	65;64;64	G;G,A;T	65;63,1;64	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	566	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	942	32.3	1	SNP	p	A12S	0	.	.	34	36	GCA	343	345	GCA	69;69;68	G;C;A	68;69;68	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1928	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	2068	50.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
